A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer.
Clin Lung Cancer
2013
14
3
215-23
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.
Lancet Oncol
2013
14
6
490-9
Hof1 and Rvs167 have redundant roles in actomyosin ring function during cytokinesis in budding yeast.
PLoS ONE
2013
8
2
e57846
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.
N Engl J Med
2013
369
19
1783-96
Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation.
Haematologica
2013
98
5
765-70
A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies.
Leuk Res
2013
37
9
1100-6
Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trial.
J Clin Oncol
2013
31
25
3110-8
Activating germline R776H mutation in the epidermal growth factor receptor associated with lung cancer with squamous differentiation.
J Clin Oncol
2013
31
10
e161-4
Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation.
Immunity
2013
38
4
655-68
Evidence of an autoregulatory mechanism of regional bone blood flow at hypotension.
Arch Orthop Trauma Surg
2013
133
9
1233-41